1 August 2024 false Taxfiler 2024.6 12727669 business:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12727669 2024-07-31 12727669 2024-08-01 2025-07-31 12727669 business:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 12727669 business:FilletedAccounts 2024-08-01 2025-07-31 12727669 2025-07-31 12727669 business:Director1 2024-08-01 2025-07-31 12727669 business:RegisteredOffice 2024-08-01 2025-07-31 12727669 2024-07-31 12727669 core:WithinOneYear 2025-07-31 12727669 core:WithinOneYear 2024-07-31 12727669 countries:EnglandWales 2024-08-01 2025-07-31 12727669 2023-08-01 2024-07-31 12727669 business:Micro-entities 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure
Company Registration No. 12727669 (England and Wales)
Generik Pharma Limited Unaudited accounts for the year ended 31 July 2025
Generik Pharma Limited Annual report and unaudited accounts for the year ended 31 July 2025
CONTENTS
PAGE
Company information
3
Statement of financial position
4
- 2 -
Generik Pharma Limited Company Information for the year ended 31 July 2025
Director
Mariam Bibi Dad
Company Number
12727669 (England and Wales)
Registered Office
15 Charters Drive Middlebeck Newark Nottinghamshire NG24 3XD England
Accountants
AIC ACCOUNTANTS LTD 71 Tudor Court South WEMBLEY MIDDLESEX HA9 6SE
- 3 -
Generik Pharma Limited Statement of Financial Position as at 31 July 2025
2025
2024
£
£
Current assets
106
70
Creditors: amounts falling due within one year
(10,076)
(11,476)
Net current liabilities
(9,970)
(11,406)
Total assets less current liabilities
(9,970)
(11,406)
Accruals and deferred income
(5,000)
-
Net liabilities
(14,970)
(11,406)
Capital and reserves
(14,970)
(11,406)
NOTES TO THE ACCOUNTS
1 Statutory information
Generik Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 12727669. The registered office is 15 Charters Drive, Middlebeck, Newark, Nottinghamshire, NG24 3XD, England.
2 Director's advances, credit and guarantees
There were no advances and credit, including terms and Interest rates
There were no guarantees and their terms during the accounting period.
3 Guarantees and other financial commitments
There were no capital commitment during the accounting period.
There were no financial commitments during the accounting period
There were no contingent liabilities during the accounting period.
4 Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 4 -
Generik Pharma Limited Statement of Financial Position as at 31 July 2025 (continued)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 11 April 2026
Mariam Bibi Dad Director Company Registration No. 12727669
- 5 -